U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07425002) titled 'Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM)' on Feb. 16.
Brief Summary: This study aims to provide information about the genomics of your breast cancer which your oncologist can use to enhance the treatment of your disease possibly enabling more targeted and personalised therapy.This study will carry out TruSight Oncology Comprehensive (TSOComprehensive) testing on breast cancer tumour tissue that was collected at the time of your breast cancer diagnosis or during your breast surgery or if you have brain metastasis and you have had a biopsy for this. The TruSight Oncology Comprehensiv...